Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Mycosis Fungoides × Interferon alpha-2 × Clear all

Phase

Phase 4 1 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1 Dermatologic 1

Conditions

Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Precancerous Conditions 1 Mycosis Fungoides 1 Lymphoma, T-Cell, Cutaneous 1 Lymphoma 1 HTLV-I Infections 1 Conjunctival Intraepithelial Neoplasia 1

Interventions

denileukin diftitox 2 Methoxsalen 1 Methotrexate 1 Introns 1 Interferon alpha-2 1 Clorazepate Dipotassium 1 Bexarotene 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02323659 2022-01-13

Comparison of Methotrexate Versus Interferon-alfa 2b in Patients With Primary Cutaneous T-cell Lymphomas

Polish Lymphoma Research Group

Phase 4 Terminated

DermatologicLymphoid

Mycosis Fungoides, Lymphoma, T-Cell, Cutaneous

Data powered by HemOnc (CC BY 4.0) Colophon ⚡